Kyowa Hakko Kirin

Kyowa Hakko Kirin signs AI drug R&D deal with InveniAI
Kyowa Hakko Kirin signs AI drug R&D deal with InveniAI
Pharmaforum
artificial intelligence
machine learnings
InveniAI
Kyowa Hakko Kirin
drug discovery
Flag link:
FDA Approves Eight Novel Drugs in August
FDA Approves Eight Novel Drugs in August
BioSpace
Kyowa Hakko Kirin
Poteligeo
Alnylam
Onpattro
Amicus Therapeutics
Galafold
TherapeuticMD
Annovera
Biocodex
Diacomit
Dompe Group
Oxervate
Shire
Takhzyro
Merck
Pifeltro
Flag link:
After seeing POC data, Kyowa advances Parkinson’s program despite being dropped by Lundbeck
After seeing POC data, Kyowa advances Parkinson’s program despite being dropped by Lundbeck
Fierce Biotech
Kyowa Hakko Kirin
Parkinson's Disease
KW-6356
Lundbeck
Flag link:
Coffee Fuels Drive for Drugs for Parkinson’s to Dementia
Coffee Fuels Drive for Drugs for Parkinson’s to Dementia
Bloomberg
caffeine
Parkinson's Disease
Merck
Kyowa Hakko Kirin
Nouriast
Flag link:
Daiichi Sankyo, Kyowa Hakko Signal More Japanese Drug Takeovers
Daiichi Sankyo, Kyowa Hakko Signal More Japanese Drug Takeovers
Bloomberg
Japan
Kyowa Hakko Kirin
Daiichi Sankyo
Plexxikon
Prostrakan
M&A
Flag link:
M&A fills patent holes, fuels geographic expansion
M&A fills patent holes, fuels geographic expansion
Fierce Pharma
M&A
patents
Kyowa Hakko Kirin
Prostrakan
Forest Labs
Clinical Data
Amoun
Flag link:
Biotech's Biggest R&D Spenders 2010
Biotech's Biggest R&D Spenders 2010
Fierce Biotech
biotech
R&D
Amgen
Biogen Idec
Gilead Sciences
Genzyme
Celgene
Kyowa Hakko Kirin
Vertex Pharmaceuticals
Life Technologies
CSL
Amylin
Genmab
Cubist Pharmaceuticals
MannKind
companies
Merial
Flag link:
Biovail Enters into License Agreement with Kyowa Hakko Kirin
Biovail Enters into License Agreement with Kyowa Hakko Kirin
Pipeline Review
Biovail
Kyowa Hakko Kirin
Parkinson's Disease
Istradefylline
Flag link: